Amgen: Guggenheim Raises PT to $347, Maintains Neutral Rating

Friday, Feb 6, 2026 10:07 am ET1min read
AMGN--

Amgen: Guggenheim Raises PT to $347, Maintains Neutral Rating

Amgen: Guggenheim Raises PT to $347, Maintains Neutral Rating

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet